Leukemia, Acute

21 registered clinical trials studyying Leukemia, Acute — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokin NCT07296445	SDK Therapeutics, Inc.	Phase 3
Withdrawn	Physical Activity and Quality of Life in Childhood Cancersurvivors- a Long-term Follow-up NCT07046481	Region Skane	N/A
Active Not Recruiting	Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients NCT05823571	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 1
Completed	Emotion and Symptom-focused Engagement for Caregivers (EASE-CG) Pilot Study NCT05236296	University Health Network, Toronto	N/A
Completed	Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignanci NCT04710212	Duke University	—
Active Not Recruiting	Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS NCT04482894	University of Virginia	Phase 2
Completed	Clinical Characteristics of Patients With Leukemia and COVID-19 NCT04745416	Hospital General de Mexico	—
Completed	Rehabilitation Needs of the Malaysian Haematological Cancer Survivors NCT04236063	University of Malaya	—
Unknown	Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT NCT03336632	Sichuan University	Phase 2
Completed	Population Pharmacokinetics and Safety of Oral Posaconazole in Children With Leukemia NCT04194086	Zhujiang Hospital	Phase 1 / Phase 2
Recruiting	Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancie NCT03680677	Abramson Cancer Center at Penn Medicine	—
Completed	Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic NCT03434704	Ciceri Fabio	Phase 2
Unknown	Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology NCT06335277	European Institute of Oncology	—
Completed	The SMART CART Study: Health Information Technology NCT04051216	University of Michigan Rogel Cancer Center	N/A
Completed	Clinical Application of Novel Panels for Early Precision Diagnosis and Relapse Prediction in High-risk Leukemi NCT03297476	Zhongda Hospital	—
Unknown	Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL NCT03553238	Nanfang Hospital, Southern Medical University	Phase 2 / Phase 3
Unknown	Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL NCT03564470	Nanfang Hospital, Southern Medical University	Phase 2 / Phase 3
Unknown	Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL NCT03564704	Nanfang Hospital, Southern Medical University	Phase 2 / Phase 3
Terminated	Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT NCT03963024	IRCCS San Raffaele	Phase 1
Completed	The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding L3 NCT05969600	Central Teaching Hospital of Peadiatrics, Baghdad	—
Terminated	Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells NCT01050764	Everett Meyer	Phase 1 / Phase 2